Exhibit 99.3

ASML — Summary U.S. GAAP Consolidated Statements of Operations ¹

	Three months ended,						Nine months ended,
(in thousands EUR, except per share data)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Net system sales		590,723			458,691			2,136,296			743,050
Net service and field option sales		105,770			96,581			323,562			272,447
Total net sales		696,493			555,272			2,459,858			1,015,497
Cost of sales		431,062			364,013			1,483,334			777,438
Gross profit on sales		265,431			191,259			976,524			238,059
Research and development costs, net of credits		130,157			115,166			388,657			351,371
Selling, general and administrative costs		51,933			37,537			165,628			119,510
Income (loss) from operations		83,341			38,556			422,239			(232,822	)
Interest income (expense)		7,059			(2,383	)		17,633			(3,652	)
Income (loss) from operations before income taxes		90,400			36,173			439,872			(236,474	)
(Provision for) benefit from income taxes		(17,106	)		(16,434	)		(29,478	)		35,069
Net income (loss)		73,294			19,739			410,394			(201,405	)
Basic net income (loss) per ordinary share		0.17			0.05			0.95			(0.47	)
Diluted net income (loss) per ordinary share2		0.17			0.05			0.94			(0.47	)
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		431,672			432,675			431,498			432,414
Diluted 2		434,491			434,975			434,859			432,414

ASML — Ratios and Other Data ¹

	Three months ended,						Nine months ended,
	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Gross profit as a % of net sales		38.1			34.4			39.7			23.4
Income (loss) from operations as a % of net sales		12.0			6.9			17.2			(22.9	)
Net income (loss) as a % of net sales		10.5			3.6			16.7			(19.8	)
Shareholders’ equity as a % of total assets		50.3			47.8			50.3			47.8
Income taxes as a % of income before income taxes		(18.9	)		(45.4	)		(6.7	)		(14.8	)
Sales of systems (in units)		37			24			126			45
ASP of systems sales (EUR million)		16.0			19.1			17.0			16.5
Value of backlog systems (EUR million)		1,028			1,353			1,028			1,353
Backlog systems (in units)		53			54			53			54
ASP of backlog systems (EUR million)		19.4			25.1			19.4			25.1
Value of booked systems (EUR million)		498			777			1,443			1,378
Net bookings (in units)		31			35			90			58
ASP of booked systems (EUR million)		16.1			22.2			16.0			23.8
Number of payroll employees in FTEs		6,907			6,529			6,907			6,529
Number of temporary employees in FTEs		1,610			917			1,610			917

ASML — Summary U.S. GAAP Consolidated Balance Sheets ¹

(in thousands EUR)	Dec 31, 2008		Sep 27, 2009
ASSETS
Cash and cash equivalents		1,109,184		1,018,028
Accounts receivable, net		463,273		382,065
Finance receivables, net		6,225		21,151
Current tax assets		87,560		—
Inventories, net		999,150		882,369
Deferred tax assets		71,780		68,962
Other assets		236,077		224,240
Total current assets		2,973,249		2,596,815
Finance receivables, net		31,030		—
Deferred tax assets		148,133		193,466
Other assets		88,197		68,061
Goodwill		131,453		128,595
Other intangible assets, net		26,692		19,037
Property, plant and equipment, net		540,640		561,684
Total non-current assets		966,145		970,843
Total assets		3,939,394		3,567,658
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,008,343		949,273
Long-term debt		647,050		660,191
Deferred and other tax liabilities		209,699		193,708
Provisions		15,495		13,506
Accrued liabilities and other liabilities		70,038		44,709
Total non-current liabilities		942,282		912,114
Total liabilities		1,950,625		1,861,387
Shareholders’ equity		1,988,769		1,706,271
Total liabilities and shareholders’ equity		3,939,394		3,567,658

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ¹

	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		73,294			19,739			410,394			(201,405	)
Depreciation and amortization		28,625			39,302			84,102			108,838
Impairment		552			9,050			2,196			16,029
Loss on disposals of property, plant and equipment		1,413			859			3,827			3,037
Share-based payments		3,686			2,786			10,362			8,879
Allowance for doubtful debts		(206	)		672			(313	)		1,836
Allowance for obsolete inventory		21,295			20,840			53,851			86,872
Deferred income taxes		2,421			(4,461	)		(31,447	)		(62,695	)
Change in assets and liabilities		(110,227	)		(154,188	)		(114,790	)		117,324
Net cash provided by (used in) operating activities		20,853			(65,401	)		418,182			78,715
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(68,237	)		(13,511	)		(188,710	)		(97,267	)
Proceeds from sale of property, plant and equipment		—			—			—			6,877
Purchases of intangible assets		(35	)		—			(35	)		—
Net cash used in financing activities		(68,272	)		(13,511	)		(188,745	)		(90,390	)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(394	)		—			(107,841	)		(86,486	)
Purchase of shares in conjunction with share-based payment plans		—			—			(87,605	)		—
Net proceeds from issuance of shares and stock options		1,439			4,183			4,966			4,714
Excess tax benefits (deficiencies) from stock options		(1,946	)		715			4,027			963
Net proceeds from other long-term debt		—			—			—			32
Redemption and/or repayment of debt		(1,280	)		(4	)		(1,280	)		(13	)
Net cash provided by (used in) financing activities		(2,181	)		4,894			(187,733	)		(80,790	)
Net cash flows		(49,600	)		(74,018	)		41,704			(92,465	)
Effect of changes in exchange rates on cash		1,695			(614	)		(347	)		1,309
Net increase (decrease) in cash & cash equivalents		(47,905	)		(74,632	)		41,357			(91,156	)

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in millions EUR, except per share data)	2008			2008			2009			2009			2009
Net system sales		590.7			380.5			101.1			183.3			458.7
Net service and field option sales		105.8			113.3			82.5			93.3			96.6
Total net sales		696.5			493.8			183.6			276.6			555.3
Cost of sales		431.1			454.8			171.2			242.2			364.0
Gross profit on sales		265.4			39.0			12.4			34.4			191.3
Research and development costs, net of credits		130.2			127.5			118.3			117.9			115.2
Selling, general and administrative costs		51.9			46.7			41.0			41.0			37.5
Income (loss) from operations		83.3			(135.2	)		(146.9	)		(124.5	)		38.6
Interest income (expense)		7.1			5.0			(1.1	)		(0.2	)		(2.4	)
Income (loss) from operations before income taxes		90.4			(130.2	)		(148.0	)		(124.7	)		36.2
(Provision for) benefit from income taxes		(17.1	)		42.2			30.8			20.7			(16.5	)
Net income (loss)		73.3			(88.0	)		(117.2	)		(104.0	)		19.7
Basic net income (loss) per ordinary share		0.17			(0.20	)		(0.27	)		(0.24	)		0.05
Diluted net income (loss) per ordinary share 2		0.17			(0.20	)		(0.27	)		(0.24	)		0.05
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		431,672			431,989			432,112			432,454			432,675
Diluted 2		434,491			431,989			432,112			432,454			434,975

ASML — Quarterly Summary Ratios and other data ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
	2008			2008			2009			2009			2009
Gross profit as a % of net sales		38.1			7.9			6.7			12.5			34.4
Income (loss) from operations as a % of net sales		12.0			(27.4	)		(80.0	)		(45.0	)		6.9
Net income (loss) as a % of net sales		10.5			(17.8	)		(63.8	)		(37.6	)		3.6
Shareholders’ equity as a % of total assets		50.3			50.5			48.0			47.7			47.8
Income taxes as a % of income before income taxes		(18.9	)		(32.4	)		(20.8	)		(16.6	)		(45.4	)
Sales of systems (in units)		37			25			11			10			24
ASP of system sales (EUR million)		16.0			15.2			9.2			18.3			19.1
Value of backlog systems (EUR million)		1,028			755			853			1,064			1,353
Backlog systems (in units)		53			41			38			43			54
ASP of backlog systems (EUR million)		19.4			18.4			22.4			24.7			25.1
Value of booked systems (EUR million)		498			127			207			394			777
Net bookings (in units)		31			13			8			15			35
ASP of booked systems (EUR million)		16.1			9.8			25.8			26.3			22.2
Number of payroll employees in FTEs		6,907			6,930			6,715			6,597			6,529
Number of temporary employees in FTEs		1,610			1,329			959			868			917

ASML — Summary U.S. GAAP Consolidated Balance Sheets ¹

	Sep 28,		Dec 31,		Mar 29,		Jun 28,		Sep 27,
(in millions EUR)	2008		2008		2009		2009		2009
ASSETS
Cash and cash equivalents		1,313.0		1,109.2		1,151.0		1,092.7		1,018.0
Accounts receivable, net		536.1		463.3		291.6		213.5		382.1
Finance receivables, net		7.4		6.2		6.2		0.1		21.1
Current tax assets		—		87.6		—		—		—
Inventories, net		1,134.0		999.1		936.8		926.1		882.4
Deferred tax assets		82.8		71.8		74.9		70.5		69.0
Other assets		261.4		236.1		240.6		220.2		224.2
Total current assets		3,334.7		2,973.3		2,701.1		2,523.1		2,596.8
Finance receivables, net		30.7		31.0		29.2		20.6		—
Deferred tax assets		139.4		148.1		173.2		198.9		193.5
Other assets		50.6		88.2		89.5		53.8		68.1
Goodwill		129.2		131.5		139.7		134.5		128.6
Other intangible assets, net		28.8		26.7		25.6		22.3		19.0
Property, plant and equipment, net		503.1		540.6		586.6		591.9		561.7
Total non-current assets		881.8		966.1		1,043.8		1,022.0		970.9
Total assets		4,216.5		3,939.4		3,744.9		3,545.1		3,567.7
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,273.0		1,008.3		1,017.5		940.9		949.3
Long-term debt		596.7		647.1		661.4		651.9		660.2
Deferred and other tax liabilities		215.2		209.7		204.9		200.6		193.7
Provisions		—		15.5		16.9		14.8		13.5
Accrued liabilities and other liabilities		8.8		70.0		48.2		45.6		44.7
Total non-current liabilities		820.7		942.3		931.4		912.9		912.1
Total liabilities		2,093.7		1,950.6		1,948.9		1,853.8		1,861.4
Shareholders’ equity		2,122.8		1,988.8		1,796.0		1,691.3		1,706.3
Total liabilities and shareholders’ equity		4,216.5		3,939.4		3,744.9		3,545.1		3,567.7

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows ¹

	Three months ended,
	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in millions EUR)	2008			2008			2009			2009			2009
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)		73.3			(88.0	)		(117.2	)		(104.0	)		19.7
Depreciation and amortization		28.6			35.1			37.9			31.6			39.3
Impairment		0.6			22.9			2.6			4.4			9.1
Loss (gain) on disposals of property, plant and equipment		1.4			0.4			2.6			(0.4	)		0.9
Share-based payments		3.7			3.2			3.5			2.6			2.8
Allowance for doubtful debts		(0.2	)		0.5			—			1.2			0.7
Allowance for obsolete inventory		21.3			85.8			22.1			43.9			20.8
Deferred income taxes		2.4			(2.7	)		(27.0	)		(31.2	)		(4.5	)
Change in assets and liabilities		(110.2	)		(194.6	)		157.7			113.8			(154.2	)
Net cash provided by (used in) operating activities		20.9			(137.4	)		82.2			61.9			(65.4	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment		(68.3	)		(71.1	)		(43.9	)		(39.9	)		(13.5	)
Proceeds from sale of property, plant and equipment		—			—			1.2			5.7			—
Net cash used in investing activities		(68.3	)		(71.1	)		(42.7	)		(34.2	)		(13.5	)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid		(0.4	)		—			—			(86.5	)		—
Net proceeds from issuance of shares and stock options		1.4			6.5			0.1			0.4			4.2
Excess tax benefits (deficiencies) from stock options		(1.9	)		(1.9	)		(0.2	)		0.5			0.7
Net proceeds from other long-term debt		—			—			—			0.1			—
Redemption and/or repayment of debt		(1.3	)		(1.1	)		—			—			—
Net cash provided by (used in) financing activities		(2.2	)		3.5			(0.1	)		(85.5	)		4.9
Net cash flows		(49.6	)		(205.0	)		39.4			(57.8	)		(74.0	)
Effect of changes in exchange rates on cash		1.7			1.2			2.4			(0.5	)		(0.7	)
Net increase (decrease) in cash & cash equivalents		(47.9	)		(203.8	)		41.8			(58.3	)		(74.7	)

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

Foreign currency risk management

The Company uses the euro as its invoicing currency in order to limit the exposure to foreign currency movements. Exceptions may occur on a customer by customer basis. To the extent that invoicing is done in a currency other than the euro, the Company is exposed to foreign currency risk.

It is the Company’s policy to hedge material transaction exposures, such as sales transactions and forecasted purchase transactions. The Company hedges these exposures through the use of foreign exchange options and forward contracts. The use of a mix of foreign exchange options and forward contracts is aimed at reflecting the likelihood of the transactions occurring.

It is the Company’s policy to hedge material remeasurement exposures. These net exposures from certain monetary assets and liabilities in non-functional currencies are hedged with forward contracts.

As of September 27, 2009 EUR 39.8 million loss is classified as other comprehensive income, net of taxes, representing the total anticipated loss to be charged to net sales, and EUR 0.9 million loss representing the total anticipated loss to be released to cost of sales when the forecasted revenue and purchase transactions occur.

ASML — Reconciliation U.S. GAAP — IFRS ¹

Net income	Three months ended,						Nine months ended,
(in thousands EUR)	Sep 28, 2008			Sep 27, 2009			Sep 28, 2008			Sep 27, 2009
Net income (loss) under U.S. GAAP		73,294			19,739			410,394			(201,405	)
Share-based payments (see Note 1)		(2,492	)		1,415			(3,009	)		2,311
Capitalization of development costs (see Note 2)		14,867			24,504			55,197			57,779
Reversal of write-downs (see Note 3)		—			28,509			—			28,509
Income taxes (see Note 4)		(3,119	)		(1,350	)		(3,081	)		(3,407	)
Net income (loss) under IFRS		82,550			72,817			459,501			(116,213	)

Shareholders’ equity	Sep 28,			Dec 31,			Mar 29,			Jun 28,			Sep 27,
(in thousands EUR)	2008			2008			2009			2009			2009
Shareholders’ equity under U.S. GAAP		2,122,848			1,988,769			1,795,951			1,691,240			1,706,271
Share-based payments (see Note 1)		(7,904	)		(6,537	)		(7,088	)		(4,918	)		(460	)
Capitalization of development costs (see Note 2)		193,780			201,717			215,452			235,945			259,665
Reversal of write-downs (see Note 3)		—			—			—			—			28,509
Income taxes (see Note 4)		5,969			4,794			3,361			2,797			1,370
Shareholders’ equity under IFRS		2,314,693			2,188,743			2,007,676			1,925,064			1,995,355

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options and stock granted to its employees after November 7, 2002. Under IFRS, at period end a deferred tax asset is computed on the basis of the tax deduction for the share-based payments under the applicable tax law and is recognized to the extent it is probable that future taxable profit will be available against which these deductible temporary differences will be utilized. Therefore, changes in the Company’s share price do affect the deferred tax asset at period-end and result in adjustments to the deferred tax asset.

As of January 1, 2006, ASML applies ASC 718 “Share-Based Payment” which requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. ASC 718’s general principle is that a deferred tax asset is established as the Company recognizes compensation costs for commercial purposes for awards that are expected to result in a tax deduction under existing tax law. Under U.S. GAAP, the deferred tax recorded on share-based compensation is computed on the basis of the expense recognized in the financial statements.

Therefore, changes in the Company’s share price do not affect the deferred tax asset recorded in the Company’s financial statements.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, ASML capitalizes certain development expenditures which are amortized over the expected useful life of the related product generally ranging between one and three years. Amortization starts when the developed product is ready for volume production. In 2008, we recognized an impairment charge for an amount of EUR 18.3 million.

Under U.S. GAAP, ASML applies ASC 730, “Accounting for Research and Development Costs”. In accordance with ASC 730, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Reversal of write-downs

Under IFRS, ASML applies IAS 2 (revised), “Inventories”. In accordance with IAS 2, reversal of a prior period write-down as a result of a subsequent increase in value of inventory should be recognized in the period in which the value increase occurs.

Under U.S. GAAP, ASML applies ASC 330 Inventory. In accordance with ASC 330 reversal of a write-down is prohibited as a write-down creates a new cost basis.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12 unrealized net income resulting from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which deferred taxes must be recognized in consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets in consolidation, give rise to a temporary difference for which prepaid taxes must be recognized in consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s rather than the purchaser’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average selling price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), including the impact of credit market deterioration on consumer confidence and demand for our customers’ products, competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

1	All quarterly information in this press release is unaudited.
2	The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans for periods in which exercises would have a dilutive effect, the calculation of diluted net income per ordinary share does not assume exercise of such options when such exercises would be antidilutive.